364 related articles for article (PubMed ID: 38111040)
1. Non-coding RNA methylation modifications in hepatocellular carcinoma: interactions and potential implications.
Shi Q; Chu Q; Zeng Y; Yuan X; Wang J; Zhang Y; Xue C; Li L
Cell Commun Signal; 2023 Dec; 21(1):359. PubMed ID: 38111040
[TBL] [Abstract][Full Text] [Related]
2. The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma.
Li D; Li K; Zhang W; Yang KW; Mu DA; Jiang GJ; Shi RS; Ke D
Front Immunol; 2022; 13():918140. PubMed ID: 35833147
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between m6A modification and non-coding RNAs in HCC.
Qiu Z; Yuan X; Wang X; Liu S
Cell Signal; 2024 May; 117():111076. PubMed ID: 38309550
[TBL] [Abstract][Full Text] [Related]
4. The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment.
Xue C; Gu X; Bao Z; Su Y; Lu J; Li L
Front Immunol; 2022; 13():847728. PubMed ID: 35281015
[TBL] [Abstract][Full Text] [Related]
5. The m6A/m5C/m1A regulator genes signature reveals the prognosis and is related with immune microenvironment for hepatocellular carcinoma.
Liu T; Sun L; Li ZZ; Yang K; Chen JM; Han XY; Qi LM; Zhou XG; Wang P
BMC Gastroenterol; 2023 May; 23(1):147. PubMed ID: 37170222
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a novel prognostic signature based on m6A/m5C/m1A-related genes in hepatocellular carcinoma.
Xiao Y; Li J; Wu J
BMC Med Genomics; 2023 Jul; 16(1):177. PubMed ID: 37525171
[TBL] [Abstract][Full Text] [Related]
7. Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications.
Wong CM; Tsang FH; Ng IO
Nat Rev Gastroenterol Hepatol; 2018 Mar; 15(3):137-151. PubMed ID: 29317776
[TBL] [Abstract][Full Text] [Related]
8. Deciphering the Divergent Gene Expression Landscapes of m6A/m5C/m1A Methylation Regulators in Hepatocellular Carcinoma Through Single-Cell and Bulk RNA Transcriptomic Analysis.
Liu HT; Rau CS; Liu YW; Hsieh TM; Huang CY; Chien PC; Lin HP; Wu CJ; Chuang PC; Hsieh CH
J Hepatocell Carcinoma; 2023; 10():2383-2395. PubMed ID: 38164510
[TBL] [Abstract][Full Text] [Related]
9. Role of non-coding RNAs in liver disease progression to hepatocellular carcinoma.
Heo MJ; Yun J; Kim SG
Arch Pharm Res; 2019 Jan; 42(1):48-62. PubMed ID: 30610616
[TBL] [Abstract][Full Text] [Related]
10. Exploration and validation of a combined Hypoxia and m6A/m5C/m1A regulated gene signature for prognosis prediction of liver cancer.
Ren M; Fan B; Cao G; Zong R; Feng L; Sun H
BMC Genomics; 2023 Dec; 24(1):776. PubMed ID: 38097948
[TBL] [Abstract][Full Text] [Related]
11. The role of m6A epigenetic modifications in tumor coding and non-coding RNA processing.
Wen T; Li T; Xu Y; Zhang Y; Pan H; Wang Y
Cell Commun Signal; 2023 Dec; 21(1):355. PubMed ID: 38102645
[TBL] [Abstract][Full Text] [Related]
12. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
[TBL] [Abstract][Full Text] [Related]
13. Role of m6A RNA methylation in the development of hepatitis B virus-associated hepatocellular carcinoma.
Zhang C; Dai D; Zhang W; Yang W; Guo Y; Wei Q
J Gastroenterol Hepatol; 2022 Nov; 37(11):2039-2050. PubMed ID: 36066844
[TBL] [Abstract][Full Text] [Related]
14. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in hepatocellular carcinoma.
Huang X; Qiu Z; Li L; Chen B; Huang P
Aging (Albany NY); 2021 Aug; 13(16):20698-20715. PubMed ID: 34461607
[TBL] [Abstract][Full Text] [Related]
15. ncRNA-mediated fatty acid metabolism reprogramming in HCC.
Xu K; Xia P; Chen X; Ma W; Yuan Y
Trends Endocrinol Metab; 2023 May; 34(5):278-291. PubMed ID: 36890041
[TBL] [Abstract][Full Text] [Related]
16. Targeting non-coding RNAs and N
Wu L; Zhang Y; Ren J
Biochem Pharmacol; 2024 May; 223():116153. PubMed ID: 38513741
[TBL] [Abstract][Full Text] [Related]
17. RNA m
Wang Z; Zhou J; Zhang H; Ge L; Li J; Wang H
Mol Oncol; 2023 Feb; 17(2):195-229. PubMed ID: 36260366
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus X protein-mediated non-coding RNA aberrations in the development of human hepatocellular carcinoma.
Zhang B; Han S; Feng B; Chu X; Chen L; Wang R
Exp Mol Med; 2017 Feb; 49(2):e293. PubMed ID: 28186085
[TBL] [Abstract][Full Text] [Related]
19. Non-coding RNAs in hepatitis C-induced hepatocellular carcinoma: dysregulation and implications for early detection, diagnosis and therapy.
Hou W; Bonkovsky HL
World J Gastroenterol; 2013 Nov; 19(44):7836-45. PubMed ID: 24307777
[TBL] [Abstract][Full Text] [Related]
20. A Novel m1A-Score Model Correlated With the Immune Microenvironment Predicts Prognosis in Hepatocellular Carcinoma.
Zhao M; Shen S; Xue C
Front Immunol; 2022; 13():805967. PubMed ID: 35401564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
